Post-marketing surveillance on treatment of 5,665 patients with atopic dermatitis using the calcineurin inhibitor pimecrolimus: Positive effects on major symptoms of atopic dermatitis and on quality of life
2006 ◽
Vol 4
(4)
◽
pp. 301-306
◽
2006 ◽
Vol 4
(4)
◽
pp. ---
2002 ◽
Vol 12
◽
pp. 381
◽
Keyword(s):
Keyword(s):